经肿瘤后缘假包膜切除垂体大腺瘤:队列研究与技术说明
该队列研究比较了2010年中前后采用后缘假包膜分离技术与传统方法切除最大径20-40mm垂体大腺瘤的效果,B组74例、A组34例。无海绵窦侵犯肿瘤的鞍内残余率A组39% vs B组10%(p<0.05),全部肿瘤A组50% vs B组18%(p<0.005),新发内分泌病与术前缺陷恢复差异无统计学意义。
要点
- 后缘假包膜分离技术可用于显微镜或内镜切除20-40mm垂体大腺瘤。
- 无海绵窦侵犯肿瘤术后鞍内残余:A组39% vs B组10%(p<0.05)。
- 全部肿瘤术后残余:A组50% vs B组18%(p<0.005),新发内分泌病差异无统计学意义。
核心结论
- 使用后缘假包膜分离平面可增强垂体大腺瘤的切除效果。
研究设计与样本
- 队列研究,前瞻性收集术前影像报告和手术细节,回顾性审查术后影像和临床随访。
- 纳入最大径20-40mm、接受显微镜经蝶切除的垂体大腺瘤患者,A组34例为新技术实施前,B组74例为实施后。
- 无侵犯肿瘤评估整个肿瘤的切除,侵犯性肿瘤仅评估鞍内成分。
主要发现
- MRI无海绵窦侵犯者:A组18例(53%),B组40例(54%)。
- 无海绵窦侵犯肿瘤术后MRI鞍内残余:A组39% vs B组10%(p<0.05)。
- 全部肿瘤(不论侵犯)术后MRI残余:A组50% vs B组18%(p<0.005)。
- 新发内分泌病:A组25% vs B组12%(p=0.098),差异无统计学意义。
- 术前缺陷恢复:A组13% vs B组27%(p=0.199),差异无统计学意义。
临床怎么用
- 作者认为后缘假包膜分离平面可增强垂体大腺瘤的切除。
局限性
- 新发内分泌病差异(p=0.098)和术前缺陷恢复差异(p=0.199)无统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Extracapsular resection of pituitary microadenomas improves remission rates, but the application of pseudocapsular techniques for macroadenomas has not been well described. In larger tumors, the extremely thin, compressed normal gland or its complete absence along the tumor's anterior surface limits the application of the traditional pseudocapsular technique that can be used for microadenomas. However, in the authors' experience, the interface between the pseudocapsule at the posterior margin of the adenoma and the compressed normal gland behind it is universally present, providing a surgical dissection plane. In mid-2010, the authors began using a new surgical technique to identify and use this interface for the resection of larger macroadenomas, a technique that can be used with the microscope or the endoscope. METHODS The authors performed a cohort study using prospectively collected preoperative imaging reports and operative details and retrospectively reviewed postoperative images and clinical follow-up of patients with a pituitary macroadenoma 20-40 mm in maximum diameter undergoing microscopic transsphenoidal resection. Since dissection of the tumor capsule only pertains to encapsulated tumor within the sella and not to tumor invading the cavernous sinus, assessment of tumor removal of noninvasive tumors emphasized the entire tumor, while that of invasive tumors emphasized the intrasellar component only. The incidence of residual tumor on postoperative imaging, new-onset endocrinopathy, and recovery of preoperative pituitary deficits was compared between patients who underwent surgery before (Group A) and after (Group B) implementation of the new technique. RESULTS There were 34 consecutive patients in Group A and 74 consecutive patients in Group B. Tumors in 18 (53%) Group A and 40 (54%) Group B patients had no evidence of cavernous sinus invasion on MRI. Use of the posterior pseudocapsule technique reduced the incidence of intrasellar residual tumor on postoperative MRI for tumors without cavernous sinus invasion (39% [Group A] vs 10%, p < 0.05) and in all tumors regardless of invasion (50% vs 18%, p < 0.005). The incidence of new endocrinopathy was less likely (25% vs 12%, p = 0.098) and the recovery of prior deficits more likely (13% vs 27%, p = 0.199) among patients treated using the pseudocapsule approach, although the differences are not statistically significant. CONCLUSIONS Use of the posterior pseudocapsule dissection plane can enhance the resection of pituitary macroadenomas.
引用
- Taylor DG, Jane JA, Oldfield EH, et al. Resection of pituitary macroadenomas via the pseudocapsule along the posterior tumor margin: a cohort study and technical note. J Neurosurg. 2017. PMID: 28820308. doi:10.3171/2017.7.JNS171658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。